[1]公欣华,周启程,顾业芸,等.二氢杨梅素改善ob/ob小鼠心脏功能及其相关作用机制研究[J].第三军医大学学报,2017,39(16):1612-1617.
 GONG Xinhua,ZHOU Qicheng,GU Yeyun,et al.Dihydromyricetin improves cardiac function in ob/ob mice and its underlying mechanism[J].J Third Mil Med Univ,2017,39(16):1612-1617.
点击复制

二氢杨梅素改善ob/ob小鼠心脏功能及其相关作用机制研究(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
39卷
期数:
2017年第16期
页码:
1612-1617
栏目:
基础医学
出版日期:
2017-08-30

文章信息/Info

Title:
Dihydromyricetin improves cardiac function in ob/ob mice and its underlying mechanism
作者:
公欣华周启程顾业芸朱俊东糜漫天
第三军医大学军事预防医学院营养与食品卫生学教研室,重庆市营养与食品安全重点实验室,重庆市医学营养研究中心
Author(s):
GONG Xinhua ZHOU Qicheng GU Yeyun ZHU Jundong MI Mantian

Department of Nutrition and Food Hygiene, Chongqing Key Laboratory of Nutrition and Food Safety, Chongqing Center of Medical Nutrition, College of Military Preventive Medicine, Third Military Medical University, Chongqing, 400038, China

关键词:
二氢杨梅素胰岛素抵抗心脏功能过氧化物酶体增殖活化受体&gamma共激活因子-1&alpha蛋白水解酶剪切Ⅲ型纤连蛋白组件包含蛋白5ob/ob小鼠
Keywords:
dihydromyricetin insulin resistance cardiac function peroxisome proliferator-activated receptor gamma coactivator 1-alpha fibronectin typeⅢdomain-containing protein 5 ob/ob mice
分类号:
R151.3; R331.31; R589.2
文献标志码:
A
摘要:

目的     探讨二氢杨梅素(dihydromyricetin, DHM)对瘦素(leptin)突变型ob/ob肥胖小鼠心脏功能的保护作用及其相关分子机制。方法      36只雄性ob/ob小鼠采用随机数字表法分为ob/ob组、DHM 50 mg/kg干预组(ob/ob+DHM 50 mg/kg)、DHM 100 mg/kg干预组(ob/ob+DHM 100 mg/kg),每组12只,干预16周;10只C57BL/6J野生型小鼠作为正常对照组(WT)。检测葡萄糖耐量和胰岛素耐量,超声心动图检测心脏功能;HE和Masson染色检测心肌的组织形态和胶原沉积;Western blot检测心肌组织中过氧化物酶体增殖活化受体γ共激活因子-1α(peroxisome proliferator activator receptor gamma coactivator-1alpha,PGC-1α)和蛋白水解酶剪切Ⅲ型纤连蛋白组件包含蛋白5(fibrone-ctin typeⅢ domain-containing protein 5,FNDC5)表达;免疫组织化学法检测心肌组织中FNDC5的表达。结果与WT组相比,ob/ob组葡萄糖耐量、胰岛素耐量明显受损(P<0.05);ob/ob组舒张期左室内径(diastolic left ventricular diameter,LVIDd)、收缩期左室内径(systolic left ventricular diameter,LVIDs)、舒张早期峰值血流速度(E峰)与舒张晚期峰值血流速度(A峰)的比值(E/A)等指标无明显变化(P>0.05),但短轴缩短分数(fraction of shortening,FS)和射血分数(ejection fraction,EF)明显降低(P<0.05),HE染色和Masson染色未发现明显的心肌细胞肥大及胶原沉积;心肌组织PGC-1α和FNDC5蛋白表达显著降低(P<0.05)。DHM干预16周后,显著改善葡萄糖耐量和胰岛素耐量受损、FS和 EF的降低、PGC-1α和FNDC5蛋白表达的降低(P<0.05)。结论     DHM改善ob/ob小鼠心脏功能与PGC-1α/FNDC5通路相关。

Abstract:

Objective       To determine the protective effect of dihydromyricetin (DHM) on cardiac function in ob/ob mice (with leptin mutation) and investigate the underlying mechanism. Methods      Thirty-six male ob/ob mice were randomly divided into 3 groups: ob/ob group, ob/ob+DHM 50 mg/kg group, ob/ob+DHM 100 mg/kg group (n=12). Ten C57BL/6J wild type mice are used as normal control (WT). Glucose tolerance and insulin tolerance were measured after 16 weeks’ treatment. Cardiac function was detected by echocardiography. Myocardial histopathology and collagen deposition were detected by HE and Masson staining. The protein expression levels of peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α) and fibronectin typeⅢ domain-containing protein 5 (FNDC5) in the myocardium were detected by Western blotting. The expression of FNDC5 in the myocardium was observed by immunohistochemical assay. Results       Glucose tolerance and insulin tolerance were obviously injured in the ob/ob mice than the WT group (P<0.05). In the ob/ob mice, no changes were found in diastolic left ventricular diameter (LVIDd), systolic left ventricular diameter (LVIDs), or ratio of velocity of early filling wave (E) to velocity of late filling wave due to atrial contraction (A) (P>0.05), or myocardial hypertrophy or collagen deposition, but notable decreases were found in short axis fractional shortening (FS) and ejection fraction (EF) (P<0.05), as well as the protein expression levels of PGC-1α and FNDC5 (P<0.05). DHM treatment for 16 weeks could significantly reverse the above changes in the ob/ob mice (P<0.05). Conclusion      DHM ameliorates cardiac function in the ob/ob mice, which might be related to PGC-1α/FNDC5 signalling pathway.

参考文献/References:

[1]INGELSSON E, SUNDSTR-M J, ARN-V J, et al. Insulin resistance and risk of congestive heart failure[J]. JAMA, 2005, 294(3): 334-341. DOI:10.1001/jama.294.3.334.
[2]SHEN Y, LINDEMEYER A K, GONZALEZ C, et al. Dihydromyricetin as a novel anti-alcohol intoxication medication[J]. J Neurosci, 2012, 32(1): 390-401.DOI:10.1523/JNEUROSCI.463911.2012.
[3]XIA J, GUO S, FANG T, et al. Dihydromyricetin induces autophagy in HepG2 cells involved in inhibition of mTOR and regulating its upstream pathways[J]. Food Chem Toxicol, 2014, 66: 7-13.DOI:10.1016/j.fct.2014.01.014.
[4]ZHANG Q, LIU J, LIU B, et al. Dihydromyricetin promotes hepatocellular carcinoma regression via a p53 activationdependent mechanism[J]. Sci Rep, 2014, 4: 4628.DOI:10.1038/srep04628.
[5]WU S, LIU B, ZHANG Q, et al. Dihydromyricetin reduced Bcl2 expression via p53 in human hepatoma HepG2 cells[J]. PLoS One, 2013, 8(11): e76886. DOI:10.1371/journal.pone.0076886.
[6]LIAO W, NING Z, MA L, et al. Recrystallization of dihydromyricetin from Ampelopsis grossedentata and its anti-oxidant activity evaluation[J]. Rejuvenation Res, 2014, 17(5): 422-429.DOI:10.1089/rej.2014.1555.
[7]SHI L, ZHANG T, LIANG X, et al. Dihydromyricetin improves skeletal muscle insulin resistance by inducing autophagy via the AMPK signaling pathway[J]. Mol Cell Endocrinol, 2015, 409: 92-102. DOI:10.1016/j.mce.2015.03.009.
[8]WRANN C D, WHITE J P, SALOGIANNNIS J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway[J]. Cell Metab, 2013, 18(5): 649-659. DOI:10.1016/j.cmet.2013.09.008.
[9]WITTELES R M, FOWLER M B. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options[J]. J Am Coll Cardiol, 2008, 51(2): 93-102. DOI:10.1016/j.jacc.2007.10.021.
[10]FANG Z Y, PRINS J B, MARWICK T H. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications[J]. Endocr Rev, 2004, 25(4): 543-567.DOI:10.1210/er.2003-0012.
[11]张平, 郭莹, 张宇, 等. PGC-1α与心脏生理和疾病关系的研究进展[J]. 山东医药, 2012, 52(28): 88-90,93. DOI: 10.3969/j.issn.1002266X.2012.28.037.
ZHANG P, GUO Y, ZHANG Y, et al. Progress in the relation between PGC-1α and cardiac physiology and diseases[J]. Shandong Med J, 2012, 52(28): 88-90,93. DOI:10.3969/j.issn.1002-266X.2012.28.037.
[12]WANG Q, LI C, ZHANG Q, et al. The effect of Chinese herbs and its effective components on coronary heart disease through PPARsPGC1α pathway[J]. BMC Complement Altern Med, 2016, 16(1): 514. DOI:10.1186/s12906-016-1496-z.
[13]XU X, YING Z, CAI M, et al. Exercise ameliorates highfat dietinduced metabolic and vascular dysfunction, and increases adipocyte progenitor cell population in brown adipose tissue[J]. AJP: Regulatory, Integrative and Comparative Physiology, 2011, 300(5): R1115-R1125. DOI:10.1152/ajpregu.00806.2010.
[14]ZADEGAN F G, GHAEDI K, KALANTAR S M, et al. Cardiac differentiation of mouse embryonic stem cells is influenced by a PPAR γ/PGC-1α-FNDC5 pathway during the stage of cardiac precursor cell formation[J]. Eur J Cell Biol, 2015, 94(6): 257-266. DOI:10.1016/j.ejcb.2015.04.002.
[15]AYDIN S, KULOGLU T, AYDIN S, et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle[J]. Peptides, 2014, 52: 68-73.DOI:10.1016/j.peptides.2013.11.024.

相似文献/References:

[1]李亚,李伟,王晶,等.抑郁状态与2型糖尿病形成各阶段代谢指标的相关性分析[J].第三军医大学学报,2012,34(16):1697.
[2]陈健,王沛坚,马丽群,等.膳食辣椒素预防高脂饮食诱导的小鼠胰岛素抵抗[J].第三军医大学学报,2013,35(07):585.
 Chen Jian,Wang Peijian,Ma Liqun,et al.Dietary capsaicin prevents insulin resistance in high fat diet-induced mice[J].J Third Mil Med Univ,2013,35(16):585.
[3]马蓉,刘建,伍丽,等.妊娠糖尿病患者胎盘组织脂联素及受体与PPAR-γ和IL-6变化的关系[J].第三军医大学学报,2011,33(13):1392.
 Ma Rong,Liu Jian,Wu Li,et al.Relationship of placental adiponectin and its receptors with PPAR-γ and IL-6 in pregnancies with gestational diabetes mellitus[J].J Third Mil Med Univ,2011,33(16):1392.
[4]金婕,陈静,阎振成.高血压病患者的胰岛素抵抗及咪达普利对其的影响[J].第三军医大学学报,2007,29(13):1343.
 JIN Jie,CHEN Jing,YAN Zhen-cheng.Insulin resistance in essential hypertension patients and effect of imidapril on it[J].J Third Mil Med Univ,2007,29(16):1343.
[5]白晓苏,张素华,丘彦,等.罗格列酮对多囊卵巢综合征患者胰岛素敏感性和β细胞功能之改善[J].第三军医大学学报,2006,28(18):1894.
[6]刘红梅,王邦琼,李启富,等.不同糖代谢人群补体C3、超敏C反应蛋白与胰岛素抵抗指数的相关性分析[J].第三军医大学学报,2011,33(16):1761.
[7]席瑞霞,舒茂琴,张平.伊贝沙坦对高血压患者内皮舒张功能和自主神经活性的干预效应[J].第三军医大学学报,2005,27(07):669.
[8]许官学,石蓓,沈长银,等.胰岛素抵抗在急性心肌梗死患者经皮冠状动脉介入治疗术后再狭窄中的作用[J].第三军医大学学报,2010,32(07):725.
[9]吴丹冬,任伟,刘静婧,等.妊娠糖尿病视黄醇结合蛋白4血清水平的研究[J].第三军医大学学报,2010,32(17):1894.
[10]庄旭东.肝硬化患者血清脂联素水平与炎性细胞因子和胰岛素抵抗的相关性研究[J].第三军医大学学报,2011,33(19):2080.

更新日期/Last Update: 2017-08-20